Iradimed (IRMD) Depreciation & Amortization (CF) (2013 - 2026)
Iradimed (IRMD) posted quarterly Depreciation & Amortization (CF) of $410000.0 for Q2 2026, up 97.12% year-over-year from $208000.0 in Q2 2025, and down 9.89% on a QoQ basis from $455000.0 in Q1 2026.
Iradimed (IRMD) Depreciation & Amortization (CF) (2013 - 2026) Analysis & Trends
Iradimed has reported Depreciation & Amortization (CF) for 14 years, with the latest figure at $410000.0 in Q2 2026.
- Depreciation & Amortization (CF) for Q2 2026 came in at $410000.0, up 97.12% year-over-year; the trailing twelve-month figure through Jun 2026 was $1.6 million (up 104.96% YoY), and the FY2025 annual result was $1.2 million, up 42.54% from the prior year.
- Depreciation & Amortization (CF) slipped to $410000.0 in Q2 2026, from $455000.0 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $494176.0 in Q2 2022 and troughed at -$692905.0 in Q4 2022.
- A 5-year average of $238047.4 and a median of $206687.5 in 2023 frame the typical range for Depreciation & Amortization (CF).
- The widest annual swing landed in 2022, when Depreciation & Amortization (CF) sank 279.23%; it then soared 134.54% in 2026.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at -$692905.0 in 2022, then soared by 129.64% to $205375.0 in 2023, then retreated by 4.95% to $195210.0 in 2024, then soared by 95.01% to $380680.0 in 2025, then climbed by 7.7% to $410000.0 in 2026.
- Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $410000.0 in Q2 2026, $455000.0 in Q1 2026, and $380680.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.43 Bn | 193.83 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.52 Bn | 123.04 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.76 Bn | 109.54 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | 355.00 Mn |
| 5 | Edwards Lifesciences | 52.20 Bn | 47.95 Bn | 1.35 Bn | 42.70 Mn |
| 6 | Dexcom | 34.51 Bn | 32.56 Bn | 830.00 Mn | 68.20 Mn |
| 7 | GE HealthCare Technologies | 33.75 Bn | 31.65 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 750.89 Mn |
| 9 | Steris | 23.09 Bn | 22.61 Bn | 684.20 Mn | 123.80 Mn |
| 10 | Iradimed | 1.11 Bn | 1.06 Bn | 15.16 Mn | 410,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 410,000.00 |
| Jun 30, 2026 | 410,000.00 |
| Mar 31, 2026 | 455,000.00 |
| Mar 31, 2026 | 455,000.00 |
| Dec 31, 2025 | 380,680.00 |
| Dec 31, 2025 | 380,680.00 |
| Sep 30, 2025 | 383,722.00 |
| Sep 30, 2025 | 383,722.00 |
| Jun 30, 2025 | 207,598.00 |
| Jun 30, 2025 | 207,598.00 |
| Mar 31, 2025 | 194,000.00 |
| Mar 31, 2025 | 194,000.00 |
| Dec 31, 2024 | 195,210.00 |
| Dec 31, 2024 | 195,210.00 |
| Sep 30, 2024 | 197,571.00 |
| Sep 30, 2024 | 197,571.00 |
| Jun 30, 2024 | 199,130.00 |
| Jun 30, 2024 | 199,130.00 |
| Mar 31, 2024 | 226,089.00 |
| Mar 31, 2024 | 226,089.00 |